+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nasal Drug Delivery Mode Market, by Therapeutic Application, by Dosage Form, by Container Type, by System Type, by End-users, by Distribution, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

  • PDF Icon

    Report

  • 167 Pages
  • June 2022
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5626491
Drug delivery refers to the technology utilized to present the drug to the desired body site for drug release and absorption. Intranasal drug delivery offers a rapid onset of therapeutic effects (local or systemic). Nasal applications of topical decongestants or anti-inflammatory drugs are most popular topical nasal drug deliveries. Nasal delivery is the logical choice for treatment of diseases in the nose and paranasal sinuses. Over the years, nasal route has gained widespread interest as a promising and an alternative route to oral and parenteral drug delivery.



Market Dynamics:


Growing prevalence of asthma and chronic obstructive pulmonary disease (COPD), increasing adoption of self-administration practices, and increasing preference for nasal drug delivery are some major factors expected to boost the growth of the global nasal drug delivery mode market over the forecast period. Asthma is a major noncommunicable disease (NCD) that affects both children and adults. For instance, according to the Asthma and Allergy Foundation of America (AAFA), more than 25 million people in the U.S. have asthma, about 1 in 13 people. Moreover, over 20 million adults aged 18 and older have asthma in the U.S., and asthma rates are highest in Black adults in the United States.

Key features of the study:

  • This report provides in-depth analysis of the global nasal drug delivery mode market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021 to 2028), considering 2020 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the nasal drug delivery mode market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck & Co., Inc., Astra Zeneca, GlaxoSmithKline Plc, Mystic Pharmaceuticals, PendoPharm Inc., Bausch Health, 3M, Cadila Pharmaceuticals, Optinose, Dr. Reddy Laboratories, Neurelis Inc., Aptar Group, Johnson & Johnson Services Inc., ENT Technologies Pty Ltd., and Becton, Dickinson and Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global nasal drug delivery mode market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery mode market.

Detailed Segmentation:

Global Nasal Drug Delivery Mode Market, By Therapeutic Application:

  • Asthma
  • Rhinitis
  • Others

Global Nasal Drug Delivery Mode Market, By Dosage Form:

  • Powder
  • Gel
  • Spray
  • Gel

Global Nasal Drug Delivery Mode Market, By Container Type:

  • Pressurized Container
  • Non Pressurized
  • Container

Global Nasal Drug Delivery Mode Market, By System Type:

  • Multi- Dose
  • Bi-Dose
  • Unit Dose

Global Nasal Drug Delivery Mode Market, By End Users:

  • Hospitals
  • Homecare Settings

Global Nasal Drug Delivery Mode Market, By Distribution:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Nasal Drug Delivery Mode Market, By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East
  • Africa
Frequently Asked Questions about the Global Nasal Drug Delivery Mode Market

What is the estimated value of the Global Nasal Drug Delivery Mode Market?

The Global Nasal Drug Delivery Mode Market was estimated to be valued at $50947.4 Million in 2022.

What is the growth rate of the Global Nasal Drug Delivery Mode Market?

The growth rate of the Global Nasal Drug Delivery Mode Market is 5.8%, with an estimated value of $75766.8 Million by 2030.

What is the forecasted size of the Global Nasal Drug Delivery Mode Market?

The Global Nasal Drug Delivery Mode Market is estimated to be worth $75766.8 Million by 2030.

Who are the key companies in the Global Nasal Drug Delivery Mode Market?

Key companies in the Global Nasal Drug Delivery Mode Market include Merck & Co., Inc., Astra Zeneca, GlaxoSmithKline Plc, Mystic Pharmaceuticals, Johnson & Johnson Services Inc., PendoPharm Inc., Bausch Health, 3M and Optinose.

Table of Contents

Table of Contents:
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Nasal Drug Delivery Mode, By Therapeutic Application
  • Market Nasal Drug Delivery Mode, By Dosage Form
  • Market Nasal Drug Delivery Mode, By Container Type
  • Market Nasal Drug Delivery Mode, By System Type
  • Market Nasal Drug Delivery Mode, By End Users
  • Market Nasal Drug Delivery Mode, By Distribution
  • Market Nasal Drug Delivery Mode, By Geography
  • Publisher Opportunity Map

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Increase in adoption of self-administration practices
  • Stringent rules and regulations
  • Outbreak of COVID-19 (pandemic)
  • Impact Analysis
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER’s Analysis
  • Merger and Acquisition Scenario

4. Nasal Drug Delivery Mode Market - Impact of Coronavirus (COVID-19) Pandemic
  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Nasal Drug Delivery Mode Market, By Therapeutic Application, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Rhinitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Nasal Drug Delivery Mode Market, By Dosage Form, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Powder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Spray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Gel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Nasal Drug Delivery Mode Market, By Container Type, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Pressurized Container
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Non-Pressurized Container
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Nasal Drug Delivery Mode Market, By System Type, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Multi-Dose
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Bi-Dose
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Unit Dose
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

9. Nasal Drug Delivery Mode Market, By End User, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

10. Nasal Drug Delivery Mode Market, By Distribution, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

11. Nasal Drug Delivery Mode Market, By Region, 2021 to 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

12. Competitive Landscape
  • Merck & Co., Inc.
  • Key Developments
  • GlaxoSmithKline Plc.
  • Key Developments
  • Astra Zeneca
  • Key Developments
  • Johnson & Johnson Services Inc.
  • Key Developments
  • Mystic Pharmaceuticals
  • Key Developments
  • Bausch Health
  • Key Developments
  • PendoPharm Inc.
  • Key Developments
  • Optinose
  • Key Developments
  • Cadila Pharmaceutical s Ltd.
  • Key Developments
  • 3M
  • Key Developments
  • Reddy Laboratories
  • Key Developments
  • Aptar Group Inc.
  • Key Developments
  • Neurelis Inc.
  • Key Developments
  • ENT Technologies Pty Ltd.
  • Key Developments
  • Becton, Dickinson and Company
  • Key Developments
  • Analyst Views

13. Section
  • Research Methodology
  • About us

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Merck & Co., Inc.
  • Astra Zeneca
  • GlaxoSmithKline Plc
  • Mystic Pharmaceuticals
  • Johnson & Johnson Services Inc.
  • PendoPharm Inc.
  • Bausch Health
  • 3M
  • Cadila Pharmaceutical s Ltd.
  • Optinose
  • Dr. Reddy Laboratories
  • ENT Technologies Pty Ltd.
  • Neurelis Inc.
  • Aptar Group
  • Becton, Dickinson and Company